Peptide Graded

Larazotide acetate

Is Larazotide acetate safe?

Adverse events similar to placebo

BSome human evidenceIn clinical trialsas of 2026-10-26

In the published randomized trials, adverse events with larazotide were similar to placebo. They were mostly headache and gut complaints. That fits a drug that is barely absorbed. No serious safety signal was reported. 3

Long-term exposure is unknown. The trials ran from weeks to a few months. No data exist for the 'leaky gut' uses promoted outside celiac disease. 3

Read the full Larazotide acetate page

More on Larazotide acetate

Citations

  1. Slifer 2021, Am J Physiol GI: larazotide acetate, a pharmacological peptide approach to tight junction regulation doi.org
  2. Beyond Celiac 2022: Phase 3 study of larazotide acetate discontinued beyondceliac.org
  3. Hoilat 2022, Clin Res Hepatol Gastroenterol: larazotide acetate for celiac disease, systematic review and meta-analysis of four RCTs doi.org

Reference information only, not medical advice. Drawn from the Larazotide acetate article, fact-checked against the cited sources. No dosing anywhere on this site.